FDA Clearance Tracker · K172348
AESKUSLIDES nDNA (Crithidia luciliae), AESKUSLIDES nDNA (Crithidia luciliae) Demo Kit, AESKUSLIDES nDNA (Crithidia luciliae) Bulk kit x5, AESKUSLIDES nDNA (Crithidia luciliae) Bulk kit x10
Last checked: Nov 20, 2026Latest source record: Feb 16, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Feb 16, 2018
Substantially Equivalent
Time to decision
197 days
Received Aug 3, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K172348
- Device name
- AESKUSLIDES nDNA (Crithidia luciliae), AESKUSLIDES nDNA (Crithidia luciliae) Demo Kit, AESKUSLIDES nDNA (Crithidia luciliae) Bulk kit x5, AESKUSLIDES nDNA (Crithidia luciliae) Bulk kit x10
- Applicant
- Aesku.Diagnostics GmbH & Co. KG
- Applicant location
- Wendeslheim, DE
- Received
- Aug 3, 2017
- Decided
- Feb 16, 2018
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Anti-Dna Antibody, Antigen And Control (LSW)
- Device class
- Class II
- Regulation
- 21 CFR 866.5100
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LSW. The earliest in FDA's data is K872085, decided Sep 1, 1987.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K172348
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Aesku.Diagnostics GmbH & Co. KG
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K172461 · Decided Mar 23, 2018 · 221 days after receipt
Device type: Test System, Antineutrophil Cytoplasmic Antibodies (Anca) (MOB) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.